JCO YIA

Journal Honors Brian G. Till, MD, As Recipient of the 2008 JCO Young Investigator Award

JCO Jun 1 2008: 2605. [Full Text] [PDF]

CELEBRATING 25 YEARS OF JCO

Commentary

Hairy Cell Leukemia: Treatment Successes in the Past 25 Years

Harvey M. Golomb

JCO Jun 1 2008: 2607–2609. [Full Text] [PDF] [From JCO 1983]

EDITORIALS

The Oncology-Rehabilitation Interface: Better Systems Needed

Mary M. Vargo

JCO Jun 1 2008: 2610–2611. [Full Text] [PDF]

Fertility Preservation: A Vital Survivorship Issue for Young Women With Breast Cancer

Ann H. Partridge

JCO Jun 1 2008: 2612–2613. [Full Text] [PDF]

Why Learning to Communicate With Our Patients Is So Important: Using Communication to Enhance Accrual to Cancer Clinical Trials

Laura A. Siminoff

JCO Jun 1 2008: 2614–2615. [Full Text] [PDF] [Publisher's Note]

Reversal of Drug Resistance in Ovarian Cancer: Where Do We Go From Here?

Stan B. Kaye

JCO Jun 1 2008: 2616–2618. [Full Text] [PDF]

Don Quixote and the Quest for Personalized Medicine

Carmen J. Allegra and Jacqueline K. Benedetti

JCO Jun 1 2008: 2619–2620. [Full Text] [PDF]

ORIGINAL REPORTS
Supportive Care and Quality of Life
	Prevalence and Treatment Patterns of Physical Impairments in Patients With Metastatic Breast Cancer
	Andrea L. Cheville, Andrea B. Troxel, Jeffrey R. Basford, and Alice B. Kornblith
	JCO Jun 1 2008: 2621–2629. [Abstract] [Full Text] [PDF]

Breast Cancer
	Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study
	Amr A. Azim, Maria Costantini-Ferrando, and Kutluk Oktay
	JCO Jun 1 2008: 2630–2635. [Abstract] [Full Text] [PDF]
	Estrogen Receptor Expression and Efficacy of Docetaxel-Containing Adjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: Results From a Pooled Analysis
	Fabrice Andre, Kristine Broglio, Henri Roche, Miguel Martin, John R. Mackey, Frederique Penault-Llorca, Gabriel N. Hortobagyi, and Lajos Pusztai
	JCO Jun 1 2008: 2636–2643. [Abstract] [Full Text] [PDF]
	Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
	Susan L. Greenspan, Adam Brufsky, Barry C. Lembersky, Rajib Bhattacharya, Karen T. Vujevich, Subashan Perera, Susan M. Sereika, and Victor G. Vogel
	JCO Jun 1 2008: 2644–2652. First published on Apr 21 2008; 10.1200/JCO.2007.15.2967. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer
	Allan Lipton, Kim Leitzel, Hilary A. Chaudri-Ross, Dean B. Evans, Suhail M. Ali, Laurence Demers, Peter Hamer, Sheryl Brown-Shimer, Karen Pierce, Victor Gaur, and Walter Carney
	JCO Jun 1 2008: 2653–2658. First published on Apr 28 2008; 10.1200/JCO.2007.15.4336. [Abstract] [Full Text] [PDF]

Epidemiology
	Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B
	Blase N. Polite, Constance Cirrincione, Gini F. Fleming, Donald A. Berry, Andrew Seidman, Hyman Muss, Larry Norton, Charles Shapiro, Kamal Bakri, Kelly Marcom, Diana Lake, Joel H. Schwartz, Clifford Hudis, and Eric P. Winer
	JCO Jun 1 2008: 2659–2665. [Abstract] [Full Text] [PDF]

Clinical Trials
	Influence of Clinical Communication on Patients' Decision Making on Participation in Clinical Trials
	Terrance L. Albrecht, Susan S. Eggly, Marci E.J. Gleason, Felicity W.K. Harper, Tanina S. Foster, Amy M. Peterson, Heather Orom, Louis A. Penner, and John C. Ruckdeschel
	JCO Jun 1 2008: 2666–2673. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
	Catherine Lhommé, Florence Joly, Joan L. Walker, Andrea A. Lissoni, Maria O. Nicoletto, Gregory M. Manikhas, Mark M.O. Baekelandt, Alan N. Gordon, Paula M. Fracasso, William L. Mietlowski, Gary J. Jones, and Margaret H. Dugan
	JCO Jun 1 2008: 2674–2682. [Abstract] [Full Text] [PDF]
	Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum/Paclitaxel–Containing First-Line Chemotherapy: An Exploratory Analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
	Christina Fotopoulou, Andreas duBois, Alexandros N. Karavas, Ralf Trappe, Behnaz Aminossadati, Barbara Schmalfeldt, Jacobus Pfisterer, and Jalid Sehouli
	JCO Jun 1 2008: 2683–2689. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
	Michael S. Braun, Susan D. Richman, Philip Quirke, Catherine Daly, Julian W. Adlard, Faye Elliott, Jennifer H. Barrett, Peter Selby, Angela M. Meade, Richard J. Stephens, Mahesh K.B. Parmar, and Matthew T. Seymour
	JCO Jun 1 2008: 2690–2698. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer
	Thomas B. Brunner, Matthias Geiger, Gerhard G. Grabenbauer, Marga Lang-Welzenbach, Tine S. Mantoni, Alexander Cavallaro, Rolf Sauer, Werner Hohenberger, and W. Gillies McKenna
	JCO Jun 1 2008: 2699–2706. [Abstract] [Full Text] [PDF]
	High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
	Xiao-Dong Zhu, Ju-Bo Zhang, Peng-Yuan Zhuang, Hong-Guang Zhu, Wei Zhang, Yu-Quan Xiong, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, and Hui-Chuan Sun
	JCO Jun 1 2008: 2707–2716. [Abstract] [Full Text] [PDF] [Publisher's Note]

Hematologic Malignancies
	Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers
	Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Upendra Hegde, Nicole Grant, Seth M. Steinberg, Mark Raffeld, Martin Gutierrez, Bruce A. Chabner, Louis Staudt, Elaine S. Jaffe, and John E. Janik
	JCO Jun 1 2008: 2717–2724. First published on Mar 31 2008; 10.1200/JCO.2007.13.1391. [Abstract] [Full Text] [PDF]
	Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Rituximab in Patients With Relapsed Follicular Lymphoma: Results of a Phase II Study
	Guillaume Cartron, Lu Zhao-Yang, Marion Baudard, Tarik Kanouni, Valérie Rouillé, Philippe Quittet, Bernard Klein, and Jean-Francois Rossi
	JCO Jun 1 2008: 2725–2731. First published on Apr 21 2008; 10.1200/JCO.2007.13.7729. [Abstract] [Full Text] [PDF]
	Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
	Alessandra Carobbio, Elisabetta Antonioli, Paola Guglielmelli, Alessandro M. Vannucchi, Federica Delaini, Vittoria Guerini, Guido Finazzi, Alessandro Rambaldi, and Tiziano Barbui
	JCO Jun 1 2008: 2732–2736. First published on Apr 28 2008; 10.1200/JCO.2007.15.3569. [Abstract] [Full Text] [PDF]
	Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
	Gema Mateo, M. Angeles Montalbán, Maria-Belén Vidriales, Juan J. Lahuerta, Maria V. Mateos, Norma Gutiérrez, Laura Rosiñol, Laura Montejano, Joan Bladé, Rafael Martínez, Javier de la Rubia, Joaquín Diaz-Mediavilla, Anna Sureda, José M. Ribera, José M. Ojanguren, Felipe de Arriba, Luis Palomera, Maria J. Terol, Alberto Orfao, and Jesús F. San Miguel
	JCO Jun 1 2008: 2737–2744. First published on Apr 28 2008; 10.1200/JCO.2007.15.4120. [Abstract] [Full Text] [PDF]

Thoracic Oncology
	Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy
	Chih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, Yeun-Chung Chang, Fu-Chang Hu, Meng-Chin Tsai, Kuan-Yu Chen, Zhong-Zhe Lin, Ching-Ju Huang, Chia-Tung Shun, Chin-Lun Huang, James Bean, Ann-Lii Cheng, William Pao, and Pan-Chyr Yang
	JCO Jun 1 2008: 2745–2753. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Quality of Life Scores Predict Survival Among Patients With Head and Neck Cancer
	Carrie A. Karvonen-Gutierrez, David L. Ronis, Karen E. Fowler, Jeffrey E. Terrell, Stephen B. Gruber, and Sonia A. Duffy
	JCO Jun 1 2008: 2754–2760. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents
	Jesús San-Miguel, Jean-Luc Harousseau, Douglas Joshua, and Kenneth C. Anderson
	JCO Jun 1 2008: 2761–2766. First published on Apr 21 2008; 10.1200/JCO.2007.15.2546. [Abstract] [Full Text] [PDF]
	Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
	Bertrand Coiffier, Arnold Altman, Ching-Hon Pui, Anas Younes, and Mitchell S. Cairo
	JCO Jun 1 2008: 2767–2778. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer

Wan-Lung Lin, Wen-Chi Lin, Jui-Yung Yang, Ya-Ching Chang, Hsin-Chun Ho, Li-Cheng Yang, Chih-Hsun Yang, Shuen-Iu Hung, and Wen-Hung Chung

JCO Jun 1 2008: 2779–2780. [Full Text] [PDF]

Strumal Carcinoid Tumor of the Ovary

Isabelle Gorin and Xavier Sastre-Garau

JCO Jun 1 2008: 2780–2781. [Full Text] [PDF]

Pseudohyperkalemia in Chronic Lymphocytic Leukemia

Kathryn J. Ruddy, David Wu, and Jennifer R. Brown

JCO Jun 1 2008: 2781–2782. [Full Text] [PDF]

ART OF ONCOLOGY

Swimming Upstream: An Advocate Reflects on Cancer Research and Social Realities

Musa Mayer

JCO Jun 1 2008: 2783–2786. [Full Text] [PDF]

CORRESPONDENCE

Stopping Trials for Benefit Can (Sometimes) Benefit Patients

Joseph L. Pater, Paul Goss, and Ralph Meyer

JCO Jun 1 2008: 2787–2788. [Full Text] [PDF]

In Reply

Ryan A. Wilcox, Benjamin Djulbegovic, Gordon H. Guyatt, and Victor M. Montori

JCO Jun 1 2008: 2788. [Full Text] [PDF]

Hepatic Arterial Infusion Chemotherapy for Metatstases From Colorectal Cancer: Is It Really the End of an Era?

Michael D'Angelica, Yuman Fong, Ronald P. DeMatteo, and William R. Jarnagin

JCO Jun 1 2008: 2788-a–2789. [Full Text] [PDF]

In Reply

Simone Mocellin and Donato Nitti

JCO Jun 1 2008: 2789–2790. [Full Text] [PDF]

The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor–Induced Cutaneous Adverse Effects

Peter Arne Gerber, Elaine Enderlein, and Bernhard Homey

JCO Jun 1 2008: 2790–2792. [Full Text] [PDF]

ERRATA

ERRATUM

JCO Jun 1 2008: 2793. [Full Text] [PDF]

ERRATUM

JCO Jun 1 2008: 2793-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.